CBUS
Cibus, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.19
+4.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.72x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.14x
- Price / sales
- 20.92x
- Price / cash flow
- -1.97x
Enterprise value
- Enterprise value
- $103.3M
- EV / sales
- 23.75x
- EV / EBITDA
- -1.79x
- EV / EBIT
- -1.91x
- Market cap
- $90.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026